Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
DeepMirror launches molecular drug design software
Video: Lithuanian company Caszyme at forefront of gene editing
Kuano raises £1.8M to accelerate quantum drug discovery
Intellegens and CPI receive grant to advance manufacture of oligonucleotide therapeutics with machine learning
10 Lithuanian startups to watch
Revolutionary self-sensing electric artificial muscles
Using DNA for data storage